In 2019，the State Drug Administration continued to promote the revision of the Regulations on the Supervision and Administration of Medical Devices，promote the construction of the regulation system，regularly carry out the post-listing supervision and consultation of medical devices with the participation of many departments，strengthen the supervision and control of high-risk products，comprehensively apply various means such as the monitoring and sampling inspection of adverse events，effectively prevent and control the safety risks of medical devices，strengthen the supervision and control of the quality of medical devices after market. In 2020，strengthen the construction of the construction of the construction of medical devices will be further enhance the construction of the construction of the construction of special supervision and regulation of medical devices